CHEST 2022
Is the use of proton pump inhibitors associated with empyema and lung abscess? Presenters at CHEST 2022 analyzed a large data base to address this question.
CHEST 2022
Is the use of proton pump inhibitors associated with empyema and lung abscess? Presenters at CHEST 2022 analyzed a large data base to address this question.
News
Clear management guidelines are needed for AKI during immune checkpoint inhibitor therapy, according to investigators.
DDW 2022, News
A team of investigators evaluated the effects of concomitant use of PPIs and advanced therapy on health care resources in patients with IBD.
DDW 2022
While food allergies may affect response to the medication, environmental allergies do not, the report says.
Drugs in the Pipeline
The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis.
News
Increased incidence of CAP was noted in stroke patients using PPIs.
News
Study is the largest to explore this potential safety issue to date.
News
Bylvay is an oral reversible inhibitor of the ileal bile acid transporter.
News
The most common inappropriate medications included proton pump inhibitors, alpha blockers, and NSAIDs.
